Lotte S. Spekhorst

Dupilumab shows long-term effectiveness in a large cohort of treatment-refractory atopic dermatitis patients in daily practice: 52-Week results from the Dutch BioDay registry

Lieneke F.M. Ariëns, Jorien van der Schaft, Lotte S. Spekhorst et al. · Journal of the American Academy of Dermatology · 2020 · 91 citations · Full text

Life Sciences, Dermatology, Immunology +12

Patient‐centered dupilumab dosing regimen leads to successful dose reduction in persistently controlled atopic dermatitis

Lotte S. Spekhorst, Daphne S. Bakker, Julia Drylewicz et al. · Allergy · 2022 · 56 citations · Full text

Medicine, Dermatology, Pharmacology +13

Dupilumab-Associated Lymphoid Reactions in Patients With Atopic Dermatitis

Celeste M. Boesjes, Lian F. van der Gang, Daphne S. Bakker et al. · JAMA Dermatology · 2023 · 54 citations · Full text

Medicine, Dermatology, Immunology +17

Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis

Lotte S. Spekhorst, Marlies de Graaf, Nicolaas P. A. Zuithoff et al. · JAMA Dermatology · 2022 · 44 citations · Full text

Medicine, Dermatology, Pharmacotherapy +15

Successful tapering of dupilumab in patients with atopic dermatitis with low disease activity: a large pragmatic daily practice study from the BioDay registry

Lotte S. Spekhorst, Celeste M. Boesjes, Laura Loman et al. · British Journal of Dermatology · 2023 · 43 citations · Full text

Pharmacy, Dermatology, Pharmacotherapy +14